Literature DB >> 25758229

Histopathological indicators of disease outcome in class IV lupus nephritis: a revisit of various indices.

Manish Rathi1, Krishan Lal Gupta, Kusum Joshi, Pramod K Gupta, Aman Sharma, Harbir Singh Kohli, Vivekanand Jha, Vinay Sakhuja.   

Abstract

Current management guidelines for lupus nephritis (LN) do not attach importance to histological indices of disease activity or chronicity. The present study was performed to evaluate the clinical relevance of these indices in determining outcomes in patients with class IV LN. We analyzed the data of all patients with biopsy-proven class IV LN seen over a 6-year period. The histopathological findings were reviewed; the activity and chronicity indices proposed by Austin [AI (Austin) & CI (Austin)] and the renal biopsy index proposed by Hill were calculated. As immunofluorescence was not done in all patients, this was excluded from calculation of the renal biopsy index, which was referred to as the modified Hill's index (MHI), which was a composite of glomerular activity index (GAI), chronicity index (CI) and tubulo-interstitial activity index (TIAI). Pearson's correlation coefficient, multilinear regression analysis and logistic analysis were performed, and p value of <.05 was considered significant. During the study period, 114 cases of LN were evaluated, of which 64 % (73/114) had class IV LN. The mean age was 26.5 years, and 92 % were females. The mean scores of AI (Austin), CI (Austin), GAI, CI, TIAI and MHI were 8.46, 2.50, 7.54, 3.06, 4.74 and 2.23, respectively. Serum creatinine correlated significantly with TIAI, CI, CI (Austin) as well as MHI, but not with AI (Austin) or GAI. The serum creatinine level was the strongest clinical parameter determining outcome, while none of the histological indices correlated with either treatment outcome or mortality. None of the histological indices performed better than serum creatinine level in determining the treatment outcomes and mortality.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25758229     DOI: 10.1007/s00296-015-3240-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  THE REPRODUCIBILITY OF SEMIQUANTITATIVE ANALYSES OF RENAL HISTOLOGY.

Authors:  C L PIRANI; V E POLLAK; F D SCHWARTZ
Journal:  Nephron       Date:  1964       Impact factor: 2.847

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

Authors: 
Journal:  Am J Kidney Dis       Date:  1992-05       Impact factor: 8.860

4.  Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome.

Authors:  G Banfi; G Mazzucco; G Barbiano di Belgiojoso; M Bestetti Bosisio; P Stratta; R Confalonieri; F Ferrario; E Imbasciati; G Monga
Journal:  Q J Med       Date:  1985-05

5.  A new morphologic index for the evaluation of renal biopsies in lupus nephritis.

Authors:  G S Hill; M Delahousse; D Nochy; E Tomkiewicz; P Rémy; F Mignon; J P Méry
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

6.  Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients.

Authors:  H C Nossent; S C Henzen-Logmans; T M Vroom; J H Berden; T J Swaak
Journal:  Arthritis Rheum       Date:  1990-07

7.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

8.  Clinical usefulness of a prognostic score in histological analysis of renal biopsy in patients with lupus nephritis.

Authors:  Shoichiro Kojo; Ken-ei Sada; Mizuho Kobayashi; Mie Maruyama; Yohei Maeshima; Hitoshi Sugiyama; Hirofumi Makino
Journal:  J Rheumatol       Date:  2009-07-31       Impact factor: 4.666

9.  Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980.

Authors:  D J Wallace; T E Podell; J M Weiner; M B Cox; J R Klinenberg; S Forouzesh; E L Dubois
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

10.  Prognostic determinants in lupus nephritis: a long-term clinicopathologic study.

Authors:  J V Donadio; G M Hart; E J Bergstralh; K E Holley
Journal:  Lupus       Date:  1995-04       Impact factor: 2.911

View more
  2 in total

1.  The Impact of Baseline Serum Creatinine on Complete Remission Rate and Long-Term Outcome in Patients with Severe Lupus Nephritis.

Authors:  Stephen M Korbet; William L Whittier; Edmund J Lewis
Journal:  Nephron Extra       Date:  2016-08-18

2.  miR-152 Attenuates the Severity of Lupus Nephritis Through the Downregulation of Macrophage Migration Inhibitory Factor (MIF)-Induced Expression of COL1A1.

Authors:  Jiayi Zheng; Ruru Guo; Yuanjia Tang; Qiong Fu; Jie Chen; Lingling Wu; Lin Leng; Richard Bucala; Yang Song; Liangjing Lu
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.